Loading clinical trials...

Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy | Clinical Trials | Clareo Health

UNKNOWNNA

Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy

Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy: A Randomized Controlled Trial

NCT04374188•Diaa Eldin Taha Ramadan Mohamed

View on ClinicalTrials.gov

Summary

Efficacy of ciprofloxacin therapy in avoidance of sepsis in patient undergoing percutanous nephrolithotomy. A randomized controlled trial.

Detailed Description

To figure out the value of oral ciprofloxacin medication in ameliorate the outcome of renal nephrolithiasis extraction via the endoscope as regard the sepsis.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1\. Patient 18 years or older
•Stones ≥ 2 cm and/or mild to moderate hydronephrosis
•Sterile mid urine stream

Exclusion Criteria

•Patients with a stent, nephrostomy tube or indwelling catheter
•Renal failure
•Fever before surgery
•Previous manipulation/procedure
•Concomitant bladder stone or tumour
•Patients with active UTI
•Contralateral renal/ureteric stone

Locations (1)

Kafrelsheikh faculty of medicine

Kafr ash Shaykh, Kafrelsheikh, Egypt

Key Dates

Start Date

September 1, 2019

Primary Completion Date

September 1, 2021

Completion Date

March 1, 2022

Last Updated

March 3, 2021

Enrollment

200

ESTIMATED participants

Conditions

Nephrolithiasis

Interventions

Ciprofloxacin

DRUG

Levofloxacin

DRUG

Contacts

Diaa Eldin Taha, MD

CONTACT

01008531384 drdiaaeldin@gmail.com

Hossam Nabeeh, MD

CONTACT

dr_hossam_nabeeh@yahoo.com

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

NCT04669886

NephrolithiasisUrosepsis

View study

RECRUITINGNA

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

NCT06576661

Kidney StoneNephrolithiasis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy

Inclusion Criteria

Exclusion Criteria

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

Bendable Suction Ureteral Access Sheath Versus Conventional Ureteral Access Sheath in Management of Renal Stones Using Flexible Ureteroscopy

National Registry of Rare Kidney Diseases

Dual-process Mechanisms of Action for sipIT Intervention Effects in Patients With Urolithiasis

HoYAG vs TFL in miniPCNL With ClearPetra